These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29962346)

  • 1. Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease.
    Talarico G; Trebbastoni A; Bruno G; de Lena C
    Curr Neuropharmacol; 2019; 17(2):176-183. PubMed ID: 29962346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.
    Tam J
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):267-76. PubMed ID: 26280171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.
    Páez JA; Campillo NE
    Curr Med Chem; 2019; 26(18):3300-3340. PubMed ID: 29484980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review.
    Kruk-Slomka M; Dzik A; Budzynska B; Biala G
    Mol Neurobiol; 2017 Dec; 54(10):8332-8347. PubMed ID: 27924524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid system and microglia in health and disease.
    Duffy SS; Hayes JP; Fiore NT; Moalem-Taylor G
    Neuropharmacology; 2021 Jun; 190():108555. PubMed ID: 33845074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptors in the kidney.
    Hryciw DH; McAinch AJ
    Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):459-64. PubMed ID: 27367912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the endocannabinoid system in drug addiction.
    Manzanares J; Cabañero D; Puente N; García-Gutiérrez MS; Grandes P; Maldonado R
    Biochem Pharmacol; 2018 Nov; 157():108-121. PubMed ID: 30217570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional interaction between GPR18 and cannabinoid CB
    Reyes-Resina I; Navarro G; Aguinaga D; Canela EI; Schoeder CT; Załuski M; Kieć-Kononowicz K; Saura CA; Müller CE; Franco R
    Biochem Pharmacol; 2018 Nov; 157():169-179. PubMed ID: 29870711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the endocannabinoid system in Alzheimer's disease: new perspectives.
    Pazos MR; Núñez E; Benito C; Tolón RM; Romero J
    Life Sci; 2004 Sep; 75(16):1907-15. PubMed ID: 15306158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the Endocannabinoid System in the Central Nervous System.
    Hu SS; Mackie K
    Handb Exp Pharmacol; 2015; 231():59-93. PubMed ID: 26408158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut feelings about the endocannabinoid system.
    Di Marzo V; Piscitelli F
    Neurogastroenterol Motil; 2011 May; 23(5):391-8. PubMed ID: 21481098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
    Benito C; Núñez E; Tolón RM; Carrier EJ; Rábano A; Hillard CJ; Romero J
    J Neurosci; 2003 Dec; 23(35):11136-41. PubMed ID: 14657172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications.
    Wolf J; Urits I; Orhurhu V; Peck J; Orhurhu MS; Giacomazzi S; Smoots D; Piermarini C; Manchikanti L; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Jun; 24(7):35. PubMed ID: 32506272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine-Induced Reinstatement of Cocaine Seeking Provokes Changes in the Endocannabinoid and
    Bystrowska B; Frankowska M; Smaga I; Niedzielska-Andres E; Pomierny-Chamioło L; Filip M
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
    Ting CH; Chi CW; Li CP; Chen CY
    Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.
    Terradillos I; Bonilla-Del Río I; Puente N; Serrano M; Mimenza A; Lekunberri L; Anaut-Lusar I; Reguero L; Gerrikagoitia I; Ruiz de Martín Esteban S; Hillard CJ; Grande MT; Romero J; Elezgarai I; Grandes P
    Glia; 2023 Apr; 71(4):866-879. PubMed ID: 36437738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
    Hutch CR; Hillard CJ; Jia C; Hegg CC
    Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Endocannabinoid System in Alzheimer's Disease: A Network Meta-Analysis.
    Liu Y; Xing H; Zhang Y; Song Y
    J Neurosci Res; 2024 Sep; 102(9):e25380. PubMed ID: 39245959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.